These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9742519)

  • 1. [Expression of variant CD44 in colorectal cancer and its relationship to liver metastasis].
    Yamaguchi A
    Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):409-14. PubMed ID: 9742519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.
    Yamaguchi A; Urano T; Goi T; Saito M; Takeuchi K; Hirose K; Nakagawara G; Shiku H; Furukawa K
    J Clin Oncol; 1996 Apr; 14(4):1122-7. PubMed ID: 8648366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of liver metastasis formation by anti-CD44 variant exon 9 monoclonal antibody.
    Seki K; Yamaguchi A; Goi T; Nakagawara G; Matsukawa S; Urano T; Furukawa K
    Int J Oncol; 1997 Dec; 11(6):1257-61. PubMed ID: 21528332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection.
    Yamaguchi A; Goi T; Seki K; Ohtaki N; Maehara M; Kobayashi T; Niimoto S; Katayama K; Hirose K; Nakagawara G; Matsukawa S
    Oncology; 1998; 55(5):400-3. PubMed ID: 9732216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.
    Kuhn S; Koch M; Nübel T; Ladwein M; Antolovic D; Klingbeil P; Hildebrand D; Moldenhauer G; Langbein L; Franke WW; Weitz J; Zöller M
    Mol Cancer Res; 2007 Jun; 5(6):553-67. PubMed ID: 17579117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
    Yamaguchi A; Goi T; Taguchi S; Ohtaki N; Seki K; Hirose K; Nakagawara G; Urano T; Furukawa K
    J Gastroenterol; 1998 Jun; 33(3):349-53. PubMed ID: 9658313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes.
    Chun SY; Bae OS; Kim JB
    J Korean Med Sci; 2000 Dec; 15(6):696-700. PubMed ID: 11194197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 with variant exons 8-10 in colorectal tumors.
    Goi T; Yamaguchi A; Takeuchi K; Nakagawa G; Yamashiro S; Furukawa K; Urano T; Shiku H
    Int J Oncol; 1996 Apr; 8(4):657-62. PubMed ID: 21544409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
    Zhang P; Feng S; Liu G; Wang H; Fu A; Zhu H; Ren Q; Wang B; Xu X; Bai H; Dong C
    Oncogene; 2016 Sep; 35(38):5056-5069. PubMed ID: 27041584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
    Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
    Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer.
    Yamaguchi A; Zhang M; Goi T; Fujita T; Niimoto S; Katayama K; Hirose K
    Oncol Rep; 2000; 7(3):541-4. PubMed ID: 10767365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis.
    Köbel M; Weichert W; Crüwell K; Schmitt WD; Lautenschläger C; Hauptmann S
    Virchows Arch; 2004 Nov; 445(5):456-64. PubMed ID: 15375658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.
    Hiraga T; Nakamura H
    Oncol Lett; 2016 Oct; 12(4):2962-2969. PubMed ID: 27698884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinicopathological factors and the correlation between the adhesion molecule CD44 variant 9 expression and pulmonary metastases from colorectal cancers.
    Goi T; Koneri K; Katayama K; Hirose K; Yamaguchi A
    Int Surg; 2002; 87(2):130-6. PubMed ID: 12222916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
    Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 variant exons 8-10 in gastric cancer.
    Yamaguchi A; Saito M; Gio T; Iida A; Takeuchi K; Hirose K; Nakagawara G; Urano T; Furukawa K; Shiku H
    Jpn J Cancer Res; 1995 Dec; 86(12):1166-71. PubMed ID: 8636005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.